NewcelX NCEL
NASDAQ NCEL
$2.89 +0.11 (+3.95%)
As of: Nov 10, 2026 · 3:34 PM EST

NewcelX (NCEL) Common Equity (2019 - 2026)

Updated

NewcelX's Common Equity was $6.04 million in Q2 2026, compared with -$15.8 million a year earlier.

Analysis

NewcelX (NCEL) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at NewcelX came in at $7.25 million.

  • In earlier years, Common Equity was -$8 million in FY2024, -$1.2 million in FY2023, $111,000 in FY2022 (-79.5%) and $542,388 in FY2021.
  • Quarterly Common Equity has moved between -$15.8 million (Q2 2025) and $7.25 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 NewcelX 10.69 Mn 4.03 Mn - 6.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.04 Mn
Dec 31, 2025 7.25 Mn
Jun 30, 2025 -15.80 Mn
Dec 31, 2024 -8.00 Mn
Jun 30, 2024 -9.27 Mn
Dec 31, 2023 -1.20 Mn
Jun 30, 2023 -4.29 Mn
Dec 31, 2022 111,000.00
Jun 30, 2022 -4.04 Mn
Dec 31, 2021 542,388.00
Jun 30, 2021 4.25 Mn
Dec 31, 2020 -8.98 Mn
Dec 31, 2019 -6.17 Mn
API Access

NewcelX Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NCEL&period=max&api_key=YOUR_API_KEY